Abstract
Summary
The finding of ganglioside in heart is further evidence of the widespread distribution of these lipids. The increase of GM2 (G) ganglioside in the heart of two patients with GM22 gangliosidosis suggests that the metabolic defect is not limited to the nervous system.
Get full access to this article
View all access options for this article.